文献速递运动医学关节外科

依折麦布/阿托伐他汀治疗高脂血症可抑制大鼠肩袖撕裂模型中的冈上肌脂肪浸润并改善骨-肌腱界面愈合

Ezetimibe/Atorvastatin, a Treatment for Hyperlipidemia, Inhibits Supraspinatus Fatty Infiltration and Improves Bone-Tendon Interface Healing in a Rotator Cuff Tear Rat Model.
PubMed 文献 · Am J Sports Med · 2025-01-01

在26只雄性Sprague-Dawley大鼠肩袖修复模型中,随机均分为对照组和EZE/ATZ组,术后EZE/ATZ组接受依折麦布(10 mg/kg/d)联合阿托伐他汀(20 mg/kg/d)治疗4周。EZE/ATZ组冈上肌脂肪浸润显著低于对照组(P < .001),胶原排列一致性(P = .005)、胶原密度(P = .003)和极限强度(P = .006)均显著高于对照组。作者认为全身EZE/ATZ给药可抑制冈上肌脂肪浸润并改善骨-肌腱界面愈合。

要点

  • EZE/ATZ组冈上肌脂肪浸润显著低于对照组(P < .001)。
  • EZE/ATZ组胶原排列一致性(P = .005)和胶原密度(P = .003)显著高于对照组。
  • EZE/ATZ组骨-肌腱界面极限强度显著高于对照组(P = .006)。

核心结论

  • 全身EZE/ATZ给药通过下调肌肉萎缩相关和脂肪浸润相关基因抑制肩袖修复后冈上肌脂肪浸润。
  • EZE/ATZ使用改善骨-肌腱界面胶原生物合成、密度和排列,并显著增加拉伸强度。

研究设计与样本

  • controlled laboratory study,26只雄性Sprague-Dawley大鼠随机均分为对照组和EZE/ATZ组,均接受肩袖肌腱修复手术。
  • 术后EZE/ATZ组接受EZE(10 mg/kg/d)联合ATZ(20 mg/kg/d)治疗4周后处死。

主要发现

  • EZE/ATZ组脂肪浸润显著低于对照组(P < .001)。
  • EZE/ATZ组肌肉萎缩和脂肪浸润相关基因标志物表达显著下调。
  • EZE/ATZ组I型胶原含量增加,胶原排列一致(P = .005),胶原密度显著高于对照组(P = .003)。
  • EZE/ATZ组骨-肌腱界面极限强度显著高于对照组(P = .006)。

临床怎么用

  • 作者认为,本研究结果强烈提倡使用EZE/ATZ以改善肩袖修复后的肩关节功能和肌腱愈合。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple factors, such as muscle fatty infiltration (FI), tendon collagen content, and collagen arrangement, determine bone-tendon interface (BTI) healing after rotator cuff (RC) repair. PURPOSE: To evaluate the effects of systemic administration of ezetimibe-atorvastatin (EZE/ATZ) combination on muscle FI and tendon collagen density and arrangement in an RC repair rat model. STUDY DESIGN: Controlled laboratory study. METHODS: A total of 26 male Sprague-Dawley rats were randomly divided equally into control and EZE/ATZ groups and subjected to RC tendon repair surgery. Postoperatively, the EZE/ATZ group rats received a combination of EZE (10 mg/kg/d) and ATZ (20 mg/kg/d) for 4 weeks, after which they were sacrificed. Oil Red O staining was used to assess FI in the supraspinatus muscle. The expression of biomarkers related to muscle atrophy and FI was measured using quantitative real-time polymerase chain reaction. For the qualitative and quantitative analysis of FI-related biomarkers, immunohistochemical staining was performed. Biomechanical and histological analyses were performed to evaluate the quality of BTI healing after RC repair. RESULTS: The EZE/ATZ group showed significantly lower FI compared with the control group (P < .001) and significantly downregulated expression of gene markers related to muscle atrophy and FI. On histological analysis, the EZE/ATZ group exhibited increased collagen type I contents, consistent collagen arrangement (P = .005), and significantly higher collagen density (P = .003) compared with the control group. Biomechanical analysis of the BTI healing revealed that the EZE/ATZ group had significantly increased ultimate strength (P = .006) compared with the control group. CONCLUSION: Systemic EZE/ATZ administration suppressed supraspinatus FI by downregulating muscle atrophy-related and FI-related genes after RC repair. Additionally, EZE/ATZ use improved collagen biosynthesis, density, and arrangement at the BTI and significantly increased tensile strength. CLINICAL RELEVANCE: The results of the current study strongly advocate the use of EZE/ATZ to improve shoulder function and tendon healing after RC repair.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Yoon JP, Park SJ, Kim DH, et al. Ezetimibe/Atorvastatin, a Treatment for Hyperlipidemia, Inhibits Supraspinatus Fatty Infiltration and Improves Bone-Tendon Interface Healing in a Rotator Cuff Tear Rat Model. Am J Sports Med. 2025. PMID: 39741475. doi:10.1177/03635465241299408

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。